Keywords: Internal cooperation; developing countries; ACC
A two-week Advanced Course of Vaccinology will be organised annually from 2005 to 2007 at the Veyrier-du-Lac Conference Centre by Mérieux Foundation and University of Geneva.
The course will comprise top-level lectures, followed by interactive discussions and specific practical exercises in small working groups. Particular attention will be given to vaccines against HIV, tuberculosis and malaria. An important aspect of the course will be the promotion of contacts and international networks. Care will be taken to maintain a full independence from any influence of a commercial nature. English will be the official language.Each year, an international scientific committee will select 60 participants, including 30 from developing countries (DC), associated candidate countries (ACC), and East European countries; 20 out of the 30 will be from DC. Among them, the aim will be to select ten participants from sub-Saharan Africa. The course will be targeted at young professionals or those soon to be involved in vaccine-related research and strategic issues.
The course will also be co-sponsored by US-NIH, CDC, WHO, ESPID, University of Geneva, Johns Hopkins SPH and main vaccine producers, and they will provide lecturers. An independent evaluation is planned. Funding from the EC will ensure that scientists from developing countries, associated candidate countries (ACC), Russia, other newly independent states (NIS), and the western Balkans will benefit from fellowships for travel, housing and registration. Other participants will be asked to contribute to course expenses (registration fee) with a reduced rate for academia and governmental agencies.
The overall objective of this training is to create a critical mass of people, in Europe and in developing countries, with a sufficiently broad knowledge of vaccinology to be able to play a leading role in decision-making processes related to (i) pre-clinical vaccine research (go/no-go), (ii) design and monitoring of clinical trials, (iii) vaccine safety issues, (iv) selection of new and appropriate vaccination strategies, including economic aspects, and (v) communication.
17, rue Bourgelat
69227 Lyon Cedex 02
Tel: +41 22 379 5783/5777
Fax: +41 22 379 5801
|Nº||Principal Scientific Participants||Official Address||Other Information|
|2||Claire-A. Siegrist||CMU- Centre of Vaccinology
1, rue Michel-Servet CH1211- Geneva 4 Switzerland
|Tel: +41 22 379 7522
Fax: +41 22 379 1180